Product Images Rosuvastatin Calcium

This is a description of Rosuvastatin tablets, USP 10 mg, a medication that comes in a box containing 100 tablets (10x10). The tablets are produced by Mekson Corporation in Mandacuay. The text includes a product code (NOC 63739.234-10) and some additional information.*

This is a statistical summary of a research study comparing the efficacy of Rosuvastatin (RSV) to a placebo treatment. The hazard ratio (HR) for Rosuvastatin is 0.56 with a 95% confidence interval of 0.46 to 0.69, indicating a significant difference between the two groups (P<0.001). The table shows the number at risk in each group over time.*

This text provides data on the effectiveness of Rosuvastatin 20 mg compared to placebo in reducing cardiovascular events. The hazard ratios for different endpoints such as primary major cardiovascular events (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization are given. The results show a significant reduction in MCE and other events with Rosuvastatin compared to placebo, as indicated by the hazard ratios and p-values. The information also includes the event rates per 1000 patient-years for each endpoint. Additionally, it mentions that cardiovascular death includes fatal MI, fatal stroke, sudden death, and other adjudicated causes of cardiovascular death.*